Jump to: Page Content, Site Navigation, Site Search,
You are seeing this message because your web browser does not support basic web standards. Find out more about why this message is appearing and what you can do to make your experience on this site better.
BMJ 2005;330:480 (26 February), doi:10.1136/bmj.330.7489.480
| The first 150 words of the full text of this article appear below. |
EDITORThe issue of trial registration has been considered for years but has only recently become a major issue, as underlined also by the International Committee of Medical Journal Editors (ICMJE) initiative.1
Although a single, all inclusive, worldwide register would be optimal, areas such as paediatrics need special attention since difficulties in carrying out paediatric studies have led to a lack of drug safety and efficacy knowledge in children.2 To facilitate collaborative research and identify areas where paediatric research is needed, the DEC-net international register (www.dec-net.org), supported by the European Union under its Fifth Framework Programme as a three year feasibility study,3 was activated in 2004. DEC-net complies with the criteria listed in the meta-Register of Controlled Trials (http://controlled-trials.com/mrct) to allow for future collaboration.
DEC-net fits ICMJE's criteria, is free of charge, and is designed for use by the general public and health professionals. It
M Bonati, head
mother_child@marionegri.it, Laboratory for Mother and Child Health, Mario Negri Pharmacological Research Institute, Via Eritrea 62, 20157 Milan, Italy
C Pandolfini, senior researcher
Laboratory for Mother and Child Health, Mario Negri Pharmacological Research Institute, Via Eritrea 62, 20157 Milan, Italy
DEC-net collaborative group
Read all Rapid Responses